CD4 and COVID-19: Similar to earlier studies, in their study, Bhatt et al. [39] highlighted the exacerbated vulnerability of severe COVID-19 patients to opportunistic fungal infections like mucormycosis, driven by the significant reduction in T lymphocytes, CD4+ T, and CD8+ T cells observed in approximately 85% of these patients.